Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
EHR advisory improves infection screening in patients with autoimmune, rheumatic diseases
An automated best practice advisory within the electronic health record can improve infectious disease screening in patients with autoimmune and rheumatic conditions, according to data published in Arthritis Care & Research.
Beyond obesity care: Flood of popular weight loss drugs opens new doors, obstacles in GI
A surge of blockbuster anti-obesity drugs has dramatically changed the landscape for chronic weight management and opened new avenues of research in gastrointestinal and liver disease alongside concerns for potential GI side effects.
Log in or Sign up for Free to view tailored content for your specialty!
Fibrosis-4 may be ‘better screening tool’ for advanced NAFLD fibrosis in lean patients
Although fibrosis-4 index and NAFLD fibrosis score did not significantly differ in diagnosing advanced fibrosis in nonalcoholic fatty liver disease, fibrosis-4 may be a better screening tool in lean patients, according to a study.
Three key steps to take when considering a practice sale or merger
Mergers and acquisitions have come to private practice medicine during the last 5 years — and in a big way. It would be difficult to find a physician of any specialty in any U.S. location who is not aware of this trend.
Q&A: Causes of hepatocellular carcinoma ‘differ remarkably’ by race, ethnicity
Rates of hepatocellular carcinoma caused by alcohol-related disease and nonalcoholic fatty liver disease are on the rise, especially among Hispanic individuals, according to research in Clinical Gastroenterology and Hepatology.
‘Ask me about PBC’ campaign calls on patients to speak up for rare liver disease
International Primary Biliary Cholangitis Day, celebrated on September 10, aspires to raise awareness of the challenges that patients with this rare liver disease face and how their stories can help advance diagnosis, treatment and care.
FDA grants orphan drug designation to inhaled therapy for alpha-1 antitrypsin deficiency
The FDA granted orphan drug designation for KB408 for the treatment of alpha-1 antitrypsin deficiency, according to a press release from Krystal Biotech.
High out-of-pocket costs may lower rifaximin adherence for hepatic encephalopathy
Researchers reported low rifaximin treatment retention among patients with hepatic encephalopathy, with 30-day out-of-pocket treatment costs in excess of $150 among the factors associated with poor adherence.
RESPONSE topline data: Seladelpar normalized alkaline phosphatase, reduced pruritus in PBC
Seladelpar reduced serum alkaline phosphatase and bilirubin at 12 months in more than 60% of patients with primary biliary cholangitis compared with 20% of placebo-treated patients, according to manufacturer, CymaBay Therapeutics.
Female surgeons have better outcomes in cholecystectomies but longer operating times
Female surgeons had fewer surgical and total complications in elective and acute care cholecystectomies but longer operating times compared with male surgeons, according to data in JAMA Surgery.